REFERENCES
- Abdou H. M. Dissolution, Bioavailability & Bioequivalence. Mack, , Pennsylvania 1989; 265–284
- Ford J. L. Pharm. Acta Helv. 1986; 61: 69–88
- Yamamoto K., Nakano M., Arita T., Takayama Y., Nakai Y. J. Pharm. Sci. 1976; 65: 1484–1488
- Nozawa Y., Mizumoto T., Higashide F. Pharm. Acta Helv. 1986; 61: 337–341
- Liversidge G. G., Cundy K. C. Int. J. Pharm. 1995; 125: 91–97
- Liversidge G. G., Conzentino P. Int. J. Pharm. 1995; 125: 309–313
- Sugimoto M., Okagaki T., Narisawa S., Koida Y., Nakajima K. Int. J. Pharm. 1998; 160: 11–19
- Kubo H., Osawa T., Takashima K., Mizobe M. Biol. Pharm. Bull. 1996; 19: 741–747
- Bates T. R., Gibaldi M., Kanig J. L. J. Pharm. Sci. 1966; 55: 191–199
- Miyazaki S., Inoue H., Yamahira T., Nadai T. Chem. Pharm. Bull. 1979; 27: 2468–2472
- Otsuka M., Matsuda Y. Chem. Pharm. Bull. 1994; 42: 2382–2384
- Otsuka M., Matsuda Y. J. Pharm. Sci. 1995; 84: 1434–1437
- Otsuka M., Matsuda Y., Japan Patent No. Hei 8-48638, 1996
- Parrott E. L. J. Pharm. Sci. 1974; 63: 813–829
- Kubo H., Mizobe M. Biol. Pharm. Bull. 1997; 20: 460–463
- Nakai Y., Fukuoka E., Nakajima S., Yamamoto K. Chem. Pharm. Bull. 1977; 25: 3340–3346
- Yakou S., Yamazaki S., Sonobe T., Sugihara M. Yakuzaigaku 1986; 46: 140–147
- Miyata M., Shibakami M., Chirachanchai S., Takemoto K., Kasai N., Miki K. Nature 1990; 343: 446–447
- Giglio E. Inclusion Compounds, J. L. Atwood, J. E.D. Davies, D. D. MacNicol. Academic Press, London 1984; 2: 207–229
- Candeloro de Sanctis S., Giglio E., Pavel V., Quagliata C. Acta Cryst. 1972; B28: 3656–3661
- Jones J. G., Schwarzbaum S., Lessinger L. Acta Cryst. 1982; B38: 1207–1215